4.5 Article

Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Applied

Diterpenoids profile of the marine sponge Chelonaplysilla erecta and candidacy as potential antitumor drugs investigated by molecular docking and pharmacokinetic studies

Nada Mohamed Abdel-Wahab et al.

Summary: This study assessed the chemical composition and antitumor activity of C. erecta crude extract (CECE) from the Chelonaplysilla genus. The results, obtained through liquid chromatography with high resolution mass spectrometry and molecular docking, provided insights into the mechanism of action for potential chemotherapeutic applications.

NATURAL PRODUCT RESEARCH (2023)

Article Chemistry, Medicinal

New 1,3,4-oxadiazoles linked with the 1,2,3-triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase

Mohamed A. Mahmoud et al.

Summary: A series of 1,3,4-oxadiazole-1,2,3-triazole hybrids were designed and synthesized, and their antiproliferative activity against human cancer cell lines was evaluated. The most active compounds showed similar activity to erlotinib, and further studies revealed their ability to induce apoptosis and inhibit cancer cell growth.

ARCHIV DER PHARMAZIE (2022)

Article Biochemistry & Molecular Biology

Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies

Ramadan A. Mekheimer et al.

Summary: A series of novel pyrimido[5,4-c]quinoline derivatives were synthesized and demonstrated to have in vitro antiproliferative activity. The compounds were evaluated for their inhibition of topoisomerase I, topoisomerase II alpha, CDK2, and EGFR. The results showed selective inhibitory activity against topoisomerase I and weak inhibitory activity against topoisomerase II alpha. Compound 30B exhibited the most potent anti-proliferative activity and moderate inhibition of CDK2. Compounds 30B, 28d, and 28c also showed significant inhibitory activity against EGFR.

BIOORGANIC CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors

Amr K. A. S. Bass et al.

Summary: In this study, twenty-one dual PIM-1/HDAC inhibitors were designed and synthesized, and some of them showed promising growth inhibition and anticancer activity, with good drug-like properties. However, further research is required to determine the specific effects of these inhibitors.

BIOORGANIC CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a] indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities

Hesham A. M. Gomaa et al.

Summary: This study developed dual-targeting EGFR and BRAF(V600E) inhibitors with potential therapeutic activity against cancer, as well as good antioxidant activity. These compounds may serve as potential drug candidates for treating cancer.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Physical

Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity

Bahaa G. M. Youssif et al.

Summary: Recent studies have shown that combining kinase inhibitors has additive and synergistic effects. Novel compounds with dual p38 alpha/BRAF(V600E) inhibitory activity have been designed and synthesized, with the presence of carboximidamide moiety being crucial for activity and some compounds showing higher binding affinities.

JOURNAL OF MOLECULAR STRUCTURE (2022)

Article Biochemistry & Molecular Biology

Antioxidant and Wound Healing Potential of Vitis vinifera Seeds Supported by Phytochemical Characterization and Docking Studies

Tarfah Al-Warhi et al.

Summary: This study demonstrates the potential of Vitis vinifera seed extract in promoting wound healing by accelerating wound closure rates, increasing TGF-beta and VEGF levels, and reducing TNF-alpha and IL-1 beta levels. Phytochemical analysis identified multiple compounds, and molecular docking experiments were performed to investigate the mechanisms of action.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases

Aliaa M. Mohassab et al.

Summary: A series of new quinoline/chalcone hybrids containing 1,2,4-triazole moiety were designed and synthesized in this study, showing moderate to good activity against various cancer cell lines. Some of these compounds exhibited promising antiproliferative activities and displayed high binding affinities in inhibiting EGFR and BRAF(V600E) kinases.

BIOORGANIC CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism

Mohammed A. S. Abourehab et al.

Summary: This review focuses on fourteen globally approved EGFR small-molecule inhibitors for cancer therapy, discussing their chemical structures, target kinases, cytotoxicity, metabolism, and potential implications for new drug design.

MOLECULES (2021)

Review Biochemistry & Molecular Biology

Chalcone Derivatives: Role in Anticancer Therapy

Yang Ouyang et al.

Summary: Chalcones, as precursors for flavonoids and isoflavonoids, have shown broad biological activities and potential as novel anticancer agents. They demonstrate multiple mechanisms against cancers and are expected to improve therapeutic efficacy in combination with other therapies. The full description of toxicity is necessary for their safe clinical use for cancer treatment.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

Apoptosis: A target for anticancer therapy with novel cyanopyridines

Magda M. F. Ismail et al.

BIOORGANIC CHEMISTRY (2020)

Review Chemistry, Medicinal

Recent developments of chalcones as potential antibacterial agents in medicinal chemistry

Wenjia Dan et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety

Mohammad M. Al-Sanea et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Review Chemistry, Medicinal

Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review

Hua-Li Qin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Editorial Material Health Care Sciences & Services

Rising cancer rates in the Arab World: now is the time for action

Mostafa Ahmed Arafa et al.

EASTERN MEDITERRANEAN HEALTH JOURNAL (2020)

Article Chemistry, Multidisciplinary

Antibacterial activity of 2-amino-3-cyanopyridine derivatives

Ibrahim Mamedov et al.

MENDELEEV COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity

Hesham A. M. Gomaa et al.

BIOORGANIC CHEMISTRY (2020)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance

Huanhuan Yin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Oncology

Kinase Inhibitors and Ovarian Cancer

Periklis Katopodis et al.

CANCERS (2019)

Article Chemistry, Medicinal

Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity

Patricia Pinto et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Khyati N. Shah et al.

NATURE MEDICINE (2019)

Article Biochemistry & Molecular Biology

Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies

Hany A. M. El-Sherief et al.

BIOORGANIC CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Design, synthesis and docking study of pyridine and thieno[2,3-b] pyridine derivatives as anticancer PIM-1 kinase inhibitors

Marwa E. Abdelaziz et al.

BIOORGANIC CHEMISTRY (2018)

Review Chemistry, Medicinal

Dual or multi-targeting inhibitors: The next generation anticancer agents

Nulgumnalli Manjunathaiah Raghavendra et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents

Adileh Ayati et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities

Khaled A. M. Abouzid et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Oncology

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib

Chao-Chi Ho et al.

JOURNAL OF THORACIC ONCOLOGY (2017)

Editorial Material Oncology

BRAF Inhibitor Unveils Its Potential against Advanced Melanoma

Adina Vultur et al.

CANCER CELL (2010)

Article Chemistry, Medicinal

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach

Ashraf H. Abadi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Chemistry, Organic

Synthesis of Heavily Substituted 2-Aminopyridines by Displacement of a 6-Methylsulfinyl Group

Simon J. Teague

JOURNAL OF ORGANIC CHEMISTRY (2008)

Article Multidisciplinary Sciences

Mutations of the BRAF gene in human cancer

H Davies et al.

NATURE (2002)